The TP53 gene, a tumor suppressor, is the most common mutated gene in breast cancer and has been reported to be more frequently altered in hormone-independent HER2+ (72%) and TNBC (80%) compared to the luminal A (12%) and B (29%) subtypes of breast cancer. This evidence concerns the gene TP53 and breast cancer.